- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione](/upload/6698/7-chloro-6-fluoro-1-2-isopropyl-4-methylpyridin-3-yl-pyrido-2-3-d-pyrimidine-2-4-1h-3h-dione_441604.gif "7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione")
7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Product Name:7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Formulae hypotheticae: C16H14ClFN4O2
Molecular pondus:348.76
CAS Subcriptio Number:2252403-82-8
![Acidum carbamicum, N-[5-[(4-methylphenyl) sulfonyl]-5H-pyrrolum[2,3-b]pyrazin-2-yl]-, ethyl este](/upload/6698/carbamic-acid-n-5-4-methylphenyl-sulfonyl-5h-pyrrolo-2-3-b-pyrazin-2-yl-ethyl-este_130782.gif "Acidum carbamicum, N-[5-[(4-methylphenyl) sulfonyl]-5H-pyrrolum[2,3-b]pyrazin-2-yl]-, ethyl este")
Acidum carbamicum, N-[5-[(4-methylphenyl) sulfonyl]-5H-pyrrolum[2,3-b]pyrazin-2-yl]-, ethyl este
Product Name:Acidi carbamicum, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolum[2,3-b]pyrazin-2-yl]-, ethyl este
Formulae hypotheticae: C16H16N4O4S
Pondus hypotheticum: 360.39
CAS Registry Number: 1869118-24-0
![tert-butyl 5-tosyl-5H-pyrrolo[2,3-b] pyrazin-2-ylcarbamate](/upload/6698/tert-butyl-5-tosyl-5h-pyrrolo-2-3-b-pyrazin-2-ylcarbamate_499453.gif "tert-butyl 5-tosyl-5H-pyrrolo[2,3-b] pyrazin-2-ylcarbamate")
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b] pyrazin-2-ylcarbamate
Product Name: tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate
Formulae hypotheticae: C18H20N4O4S
Pondus hypotheticum: 388.44
CAS Registry Number: 11201187-44-1
(3R,4S)-3-(2-Bromoacetyl) -4-ethyl-1-pyrrolidinecarboxylicum acidum phenylmethyl ester
Product Name:(3R,4S)-3-(2-Bromoacetyl) -4-ethyl-1-pyrrolidinecarboxylicum acidum phenylmethyl ester
Formulae hypotheticae: C16H20BrNO3
Molecular pondus:354.24
CAS Subcriptio Number:1428243-26-8
ABT-494 medium
Product Name:ABT-494 medium
Formulae hypotheticae: C15H19NO4
Pondus hypotheticum: 277.32
CAS Subcriptio Number:1428243-246
tert-butyl 4-((2S,5R) -5-(benzyloxyamino)piperidine-2-carboxamido)piperidine-1-carboxylata 4-methylbenzenesulfonata.
Product Name: tert-butyl 4-((2S,5R)-5-(benzyloxyamino)piperidine-2-carboxamido)piperidine-1-carboxylata 4-methylbenzenesulfonata.
Formulae hypotheticae: C23H36N4O4
Molecular pondus:432.56
CAS Subcriptio Number:1510832-19-5
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
